Elena Smith

1.1k total citations
8 papers, 93 citations indexed

About

Elena Smith is a scholar working on Oncology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elena Smith has authored 8 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Hematology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elena Smith's work include Multiple Myeloma Research and Treatments (4 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Elena Smith is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Elena Smith collaborates with scholars based in United States, United Kingdom and Netherlands. Elena Smith's co-authors include Jessica Vermeulen, Jodi Carey, Jianping Wang, Maria Krevvata, Pieter Sonneveld, Sonja Zweegman, Katherine Chastain, Meletios Α. Dimopoulos, Thierry Façon and Saad Z. Usmani and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Vaccine.

In The Last Decade

Elena Smith

8 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Smith United States 5 69 59 46 14 10 8 93
Ashley Morris Engemann United States 6 75 1.1× 34 0.6× 14 0.3× 4 0.3× 3 0.3× 7 115
Grant Vallance United Kingdom 6 55 0.8× 44 0.7× 40 0.9× 2 0.1× 30 3.0× 14 115
Divya Koura United States 6 46 0.7× 49 0.8× 26 0.6× 2 0.1× 2 0.2× 18 105
Florence Rabian France 7 44 0.6× 34 0.6× 12 0.3× 6 0.4× 17 78
Lauren Shapiro United States 5 33 0.5× 28 0.5× 17 0.4× 2 0.1× 15 1.5× 14 87
Elsa Miekoutima France 4 77 1.1× 38 0.6× 65 1.4× 1 0.1× 3 0.3× 5 143
Claire Johnston United Kingdom 7 10 0.1× 40 0.7× 50 1.1× 8 0.6× 3 0.3× 8 127
Nina Shah United States 4 97 1.4× 65 1.1× 66 1.4× 2 0.2× 5 124
Khadija Msami United States 6 22 0.3× 32 0.5× 6 0.1× 12 0.9× 5 0.5× 14 81
Kelda M. Gardner United States 6 126 1.8× 79 1.3× 28 0.6× 2 0.1× 4 0.4× 20 168

Countries citing papers authored by Elena Smith

Since Specialization
Citations

This map shows the geographic impact of Elena Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Smith more than expected).

Fields of papers citing papers by Elena Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Smith. The network helps show where Elena Smith may publish in the future.

Co-authorship network of co-authors of Elena Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Smith. A scholar is included among the top collaborators of Elena Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Smith. Elena Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Arunachalam, Balasubramanian, Jesse Bodle, Laura Couzens, et al.. (2023). Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine. Vaccine. 41(32). 4639–4647. 4 indexed citations
3.
Tevaarwerk, Amyé, et al.. (2021). Patterns and predictors of cancer‐specific patient health portal usage among patients with cancer: results from the UWCCC Survivorship Program. Cancer Medicine. 10(20). 7373–7382. 12 indexed citations
5.
Sonneveld, Pieter, Annemiek Broijl, Francesca Gay, et al.. (2019). Bortezomib, lenalidomide, and dexamethasone (VRd) ± daratumumab (DARA) in patients (pts) with transplant-eligible (TE) newly diagnosed multiple myeloma (NDMM): A multicenter, randomized, phase III study (PERSEUS).. Journal of Clinical Oncology. 37(15_suppl). TPS8055–TPS8055. 31 indexed citations
6.
Sonneveld, Pieter, Evangelos Terpos, Meletios Α. Dimopoulos, et al.. (2018). Pomalidomide and dexamethasone (pom-dex) with or without daratumumab (DARA) in patients (pts) with relapsed or refractory multiple myeloma (RRMM): A multicenter, randomized, phase 3 study (APOLLO).. Journal of Clinical Oncology. 36(15_suppl). TPS8059–TPS8059. 9 indexed citations
7.
Terpos, Evangelos, Meletios Α. Dimopoulos, Efstathios Kastritis, et al.. (2017). A multicenter, randomized, phase 3 study of pomalidomide and dexamethasone (Pom-dex) with or without daratumumab in patients with relapsed or refractory multiple myeloma (RRMM): APOLLO. Annals of Oncology. 28. v368–v369. 3 indexed citations
8.
Brenwald, N., et al.. (1995). Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques. Journal of Bioluminescence and Chemiluminescence. 10(5). 291–299. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026